Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $1.77 billion. The enterprise value is $1.34 billion.
| Market Cap | 1.77B |
| Enterprise Value | 1.34B |
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 55.99 million shares outstanding. The number of shares has increased by 2.52% in one year.
| Current Share Class | 55.99M |
| Shares Outstanding | 55.99M |
| Shares Change (YoY) | +2.52% |
| Shares Change (QoQ) | -1.06% |
| Owned by Insiders (%) | 4.11% |
| Owned by Institutions (%) | 97.28% |
| Float | 48.84M |
Valuation Ratios
The trailing PE ratio is 28.64 and the forward PE ratio is 14.68.
| PE Ratio | 28.64 |
| Forward PE | 14.68 |
| PS Ratio | 2.63 |
| Forward PS | 3.62 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 4.31 |
| P/FCF Ratio | 10.87 |
| P/OCF Ratio | 10.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.69, with an EV/FCF ratio of 8.23.
| EV / Earnings | 21.70 |
| EV / Sales | 2.01 |
| EV / EBITDA | 9.69 |
| EV / EBIT | 22.92 |
| EV / FCF | 8.23 |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.44 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.32% and return on invested capital (ROIC) is 3.60%.
| Return on Equity (ROE) | 6.32% |
| Return on Assets (ROA) | 2.76% |
| Return on Invested Capital (ROIC) | 3.60% |
| Return on Capital Employed (ROCE) | 5.50% |
| Revenue Per Employee | $991,093 |
| Profits Per Employee | $91,861 |
| Employee Count | 674 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, SUPN has paid $29.88 million in taxes.
| Income Tax | 29.88M |
| Effective Tax Rate | 32.55% |
Stock Price Statistics
The stock price has increased by +1.28% in the last 52 weeks. The beta is 0.74, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +1.28% |
| 50-Day Moving Average | 31.90 |
| 200-Day Moving Average | 34.09 |
| Relative Strength Index (RSI) | 47.88 |
| Average Volume (20 Days) | 430,122 |
Short Selling Information
The latest short interest is 3.97 million, so 7.09% of the outstanding shares have been sold short.
| Short Interest | 3.97M |
| Short Previous Month | 4.14M |
| Short % of Shares Out | 7.09% |
| Short % of Float | 8.13% |
| Short Ratio (days to cover) | 6.62 |
Income Statement
In the last 12 months, SUPN had revenue of $668.00 million and earned $61.91 million in profits. Earnings per share was $1.11.
| Revenue | 668.00M |
| Gross Profit | 590.64M |
| Operating Income | 58.61M |
| Pretax Income | 37.42M |
| Net Income | 61.91M |
| EBITDA | 138.66M |
| EBIT | 58.61M |
| Earnings Per Share (EPS) | $1.11 |
Balance Sheet
The company has $463.59 million in cash and $32.31 million in debt, giving a net cash position of $431.29 million or $7.70 per share.
| Cash & Cash Equivalents | 463.59M |
| Total Debt | 32.31M |
| Net Cash | 431.29M |
| Net Cash Per Share | $7.70 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 18.41 |
| Working Capital | 405.81M |
Cash Flow
In the last 12 months, operating cash flow was $164.15 million and capital expenditures -$804,000, giving a free cash flow of $163.35 million.
| Operating Cash Flow | 164.15M |
| Capital Expenditures | -804,000 |
| Free Cash Flow | 163.35M |
| FCF Per Share | $2.92 |
Margins
Gross margin is 88.42%, with operating and profit margins of 8.77% and 9.27%.
| Gross Margin | 88.42% |
| Operating Margin | 8.77% |
| Pretax Margin | 13.74% |
| Profit Margin | 9.27% |
| EBITDA Margin | 20.76% |
| EBIT Margin | 8.77% |
| FCF Margin | 24.45% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.52% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.49% |
| FCF Yield | 9.20% |
Analyst Forecast
The average price target for SUPN is $36.00, which is 13.57% higher than the current price. The consensus rating is "Hold".
| Price Target | $36.00 |
| Price Target Difference | 13.57% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 7.04% |
| EPS Growth Forecast (5Y) | 31.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 4.98 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.98 |
| Piotroski F-Score | 7 |